Owens David 5
5 · Nexalin Technology, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 5
Owens David
DirectorChief Medical Officer
Transactions
- Purchase
Common stock
2024-12-20$2.75/sh+1,000$2,750→ 149,293 total - Award
Stock Option (right to buy)
2024-11-07+262,500→ 262,500 totalExercise: $0.94From: 2024-11-07Exp: 2029-08-26→ Common Stock (262,500 underlying)